Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Lancet Oncol. 2014 Nov 17;15(13):1469–1480. doi: 10.1016/S1470-2045(14)71113-1

TABLE 2.

Multivariate analyses




Biochemical recurrence at 5 years
Metastatic progression at 10 years
Death from any cause at 10 years
Odds Ratio (± 95% CI) P value Odds Ratio (± 95% CI) P value Odds Ratio (± 95% CI) P value

SChLAP1 (high vs. low) 1·76 (1·28 – 2·41) 0·00044 2·45 (1·70 – 3·53) <0·0001 1·93 (1·31 – 2·85) 0·00096
Gleason score 1·56 (1·33 – 1·82) <0·0001 2·14 (1·77 – 2·58) <0·0001 2·06 (1·69 – 2·51) <0·0001
PSA 1·01 (0·99 – 1·02) 0·061 1·01 (0·99 – 1·02) 0·26 1·00 (0·99 – 1·01) 0·89
Seminal vesicle invasion 1·76 (1·25 – 2·49) 0·0013 1·44 (0·96 – 2·16) 0·074 1·79 (1·16 – 2·75) 0·0083
Surgical margin status 1·38 (1·03 – 1·86) 0·030 Not included 1·28 (0·87 – 1·89) 0·21
Extracapsular extension 1·20 (0·87 – 1·63) 0·27 1·08 (0·74 – 1·58) 0·69 1·05 (0·69 – 1·61) 0·81
Lymph node invasion Not included 1·14 (0·65 – 2·01) 0·64 1·31 (0·74 – 2·32) 0·35